These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1732538)

  • 1. The three binding domain model of adenosine receptors: molecular modeling aspects.
    Dooley MJ; Quinn RJ
    J Med Chem; 1992 Jan; 35(2):211-6. PubMed ID: 1732538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A steric and electrostatic comparison of three models for the agonist/antagonist binding site on the adenosine A1 receptor.
    van der Wenden EM; Ijzerman AP; Soudijn W
    J Med Chem; 1992 Feb; 35(4):629-35. PubMed ID: 1542091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative binding orientations of adenosine A1 receptor ligands--a test case for Distributed Multipole Analysis in medicinal chemistry.
    van der Wenden EM; Price SL; Apaya RP; IJzerman AP; Soudijn W
    J Comput Aided Mol Des; 1995 Feb; 9(1):44-54. PubMed ID: 7751869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel synthesis of xanthines: support for a new binding mode for xanthines with respect to adenosine at adenosine receptors.
    Peet NP; Lentz NL; Meng EC; Dudley MW; Ogden AM; Demeter DA; Weintraub HJ; Bey P
    J Med Chem; 1990 Dec; 33(12):3127-30. PubMed ID: 2258897
    [No Abstract]   [Full Text] [Related]  

  • 5. 8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors.
    Shimada J; Suzuki F; Nonaka H; Ishii A
    J Med Chem; 1992 Mar; 35(5):924-30. PubMed ID: 1548682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the xanthine C8-region of the adenosine A1 receptor with computer graphics.
    Van der Wenden EM; Van Galen PJ; IJzerman AP; Soudijn W
    Eur J Pharmacol; 1991 Apr; 206(4):315-23. PubMed ID: 1915591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CoMFA-based comparison of two models of binding site on adenosine A1 receptor.
    Doytchinova I
    J Comput Aided Mol Des; 2001 Jan; 15(1):29-39. PubMed ID: 11217917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 125I-labeled 8-phenylxanthine derivatives: antagonist radioligands for adenosine A1 receptors.
    Linden J; Patel A; Earl CQ; Craig RH; Daluge SM
    J Med Chem; 1988 Apr; 31(4):745-51. PubMed ID: 3351850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the second transmembrane domain of rat adenosine A1 receptor in ligand-receptor interaction.
    Xie KQ; Cao Y; Zhu XZ
    Biochem Pharmacol; 2006 Mar; 71(6):865-71. PubMed ID: 16414025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1H-imidazo[4,5-c]quinolin-4-amines: novel non-xanthine adenosine antagonists.
    van Galen PJ; Nissen P; van Wijngaarden I; IJzerman AP; Soudijn W
    J Med Chem; 1991 Mar; 34(3):1202-6. PubMed ID: 2002461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model for the antagonist binding site on the adenosine A1 receptor, based on steric, electrostatic, and hydrophobic properties.
    van Galen PJ; van Vlijmen HW; IJzerman AP; Soudijn W
    J Med Chem; 1990 Jun; 33(6):1708-13. PubMed ID: 2342066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N6,C8-distributed adenosine derivatives as partial agonists for adenosine A1 receptors.
    Roelen H; Veldman N; Spek AL; von Frijtag Drabbe Künzel J; Mathôt RA; IJzerman AP
    J Med Chem; 1996 Mar; 39(7):1463-71. PubMed ID: 8691477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ischaemia on cardiac adenosine binding sites.
    Ronca-Testoni S; Zucchi R; Limbruno U; Galbani P; Ronca G; Mariani M
    Adv Exp Med Biol; 1991; 309A():447-50. PubMed ID: 1789264
    [No Abstract]   [Full Text] [Related]  

  • 14. C2,N6-disubstituted adenosines: synthesis and structure-activity relationships.
    Trivedi BK; Bruns RF
    J Med Chem; 1989 Aug; 32(8):1667-73. PubMed ID: 2754691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing adenosine receptors using biotinylated purine derivatives.
    Jacobson KA
    Methods Enzymol; 1990; 184():668-71. PubMed ID: 2388596
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular modeling of adenosine receptors. I. The ligand binding site on the A1 receptor.
    IJzerman AP; Van Galen PJ; Jacobson KA
    Drug Des Discov; 1992; 9(1):49-67. PubMed ID: 1457698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modeling of 2-alkyloxy- and 2-aralkyloxy-adenosine A1- and A2-agonists.
    Matova MM; Nacheva RN; Boicheva SV
    Drug Des Discov; 2000; 16(4):255-70. PubMed ID: 10807032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imidazodiazepinediones: a new class of adenosine receptor antagonists.
    Daly JW; Hide I; Bridson PK
    J Med Chem; 1990 Oct; 33(10):2818-21. PubMed ID: 2213834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical modification of adenosine A1 receptors. Implications for the interaction with R-PIA, DPCPX and amiloride.
    Garritsen A; Ijzerman AP; Beukers MW; Soudijn W
    Biochem Pharmacol; 1990 Aug; 40(4):835-42. PubMed ID: 2143656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnesium-dependent enhancement of endogenous agonist binding to A1 adenosine receptors: a complicating factor in quantitative autoradiography.
    Parkinson FE; Fredholm BB
    J Neurochem; 1992 Mar; 58(3):941-50. PubMed ID: 1738001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.